BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, Sharf-Pauker N, Xiao Y, Adir O, Liang H, Shi J, Schroeder A, Conde J. Nanodelivery of nucleic acids. Nat Rev Methods Primers 2022;2:24. [PMID: 35480987 DOI: 10.1038/s43586-022-00104-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Zhang Y, Wang R. Controllable loading and release of nanodrugs in polymeric vesicles. Giant 2022;12:100126. [DOI: 10.1016/j.giant.2022.100126] [Reference Citation Analysis]
2 Eljack S, David S, Faggad A, Chourpa I, Allard-vannier E. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal. International Journal of Pharmaceutics: X 2022;4:100126. [DOI: 10.1016/j.ijpx.2022.100126] [Reference Citation Analysis]
3 Baldassi D, Ngo TMH, Merkel OM. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery. Pharm Res 2022. [DOI: 10.1007/s11095-022-03443-3] [Reference Citation Analysis]
4 Shen J, Wang J, Hao Q, Ji W, Peng H, Wu Y, Zhao R, Qiu X, Wang W, Yang J, Li Y, Zhang T, Lu Z, Zhang X. Transformable Nanotheranostics Capable of Sensoring Nucleic Acid Drugs’ Spatiotemporal Behaviors. Adv Funct Materials 2022. [DOI: 10.1002/adfm.202209749] [Reference Citation Analysis]
5 Wang Y, Liu L, Le Z, Tay A. Analysis of Nanomedicine Efficacy for Osteoarthritis. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200085] [Reference Citation Analysis]
6 D’souza A, Nozohouri S, Bleier BS, Amiji MM. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood–Brain Barrier and Towards Specific Cellular Targeting. Pharm Res 2022. [DOI: 10.1007/s11095-022-03433-5] [Reference Citation Analysis]
7 Li D, Li J, Wang S, Teng W, Wang Q. Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy. IJN 2022;Volume 17:5679-5696. [DOI: 10.2147/ijn.s383862] [Reference Citation Analysis]
8 Wan Y, Yang Y, Wu M, Feng S. Fluorinated vectors for gene delivery. Expert Opin Drug Deliv 2022. [PMID: 36184732 DOI: 10.1080/17425247.2022.2131769] [Reference Citation Analysis]
9 Johnson LT, Zhang D, Zhou K, Lee SM, Liu S, Dilliard SA, Farbiak L, Chatterjee S, Lin YH, Siegwart DJ. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model. Mol Pharm 2022. [PMID: 36154076 DOI: 10.1021/acs.molpharmaceut.2c00442] [Reference Citation Analysis]
10 Chaudhuri A, Kumar DN, Shaik RA, Eid BG, Abdel-Naim AB, Md S, Ahmad A, Agrawal AK. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy. Int J Mol Sci 2022;23:10068. [PMID: 36077466 DOI: 10.3390/ijms231710068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Sousa DP, Conde J. Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics. ACS Mater Au 2022. [DOI: 10.1021/acsmaterialsau.2c00042] [Reference Citation Analysis]
12 Farhat W, Yeung V, Ross A, Kahale F, Boychev N, Kuang L, Chen L, Ciolino JB. Advances in biomaterials for the treatment of retinoblastoma. Biomater Sci 2022. [PMID: 35959730 DOI: 10.1039/d2bm01005d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Eralp Y. Application of mRNA Technology in Cancer Therapeutics. Vaccines (Basel) 2022;10:1262. [PMID: 36016150 DOI: 10.3390/vaccines10081262] [Reference Citation Analysis]